Enlivex director Hart Gili reports initial holdings

Enlivex Ltd. director Hart Gili filed an initial ownership report showing existing equity and option positions, with no new buy or sell transactions reported.

Rhea-AI Filing Summary

Enlivex Ltd. director Hart Gili filed an initial ownership report showing existing equity and option positions, with no new buy or sell transactions reported. The filing lists direct ownership of 7,672 ordinary shares and two option grants over 66,489 and 3,382 underlying ordinary shares. One option has a strike price of $2.69 and expires on December 31, 2033, and another has a strike price of $5.34 and expires on November 17, 2032. A footnote states that one option grant vests in equal annual installments over four years beginning on November 17, 2023.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Hart Gili

Role Director

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--
holding	Option (right to buy)	--	--	--
holding	Ordinary Shares, par value NIS 0.40 per share	--	--	--

Holdings After Transaction: Option (right to buy) — 69,871 contracts (Direct); Ordinary Shares, par value NIS 0.40 per share — 7,672 shares (Direct)

Footnotes (1)

1. F1. The option vests ratably on an annual basis for 4 consecutive years beginning on November 17, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Enlivex (ENLV) director Hart Gili report in this Form 3?

Hart Gili reports existing holdings in Enlivex, including ordinary shares and stock options. The filing is an initial ownership statement, showing positions but no new purchases or sales, giving investors a snapshot of this director’s current equity exposure.

How many Enlivex (ENLV) ordinary shares does Hart Gili directly own?

Hart Gili directly owns 7,672 Enlivex ordinary shares. This amount reflects direct share ownership separate from stock options, providing clarity on the director’s immediate equity stake in the company’s ordinary share capital at the time of the filing.

What stock options over Enlivex (ENLV) shares does Hart Gili hold?

Hart Gili holds options over 66,489 underlying ordinary shares at an exercise price of $2.69 and options over 3,382 underlying ordinary shares at $5.34. These options provide potential future share ownership if exercised under the specified terms.

When do Hart Gili’s Enlivex (ENLV) stock options expire?

One option grant over Enlivex ordinary shares expires on December 31, 2033, and another expires on November 17, 2032. These expiration dates define how long the director can choose to exercise the respective options at their stated exercise prices.

How do Hart Gili’s Enlivex (ENLV) options vest over time?

A footnote states that one option grant vests in equal annual installments over four years beginning on November 17, 2023. This means portions of the option become exercisable each year, aligning the director’s incentives with longer-term company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:13 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hart Gili

(Last) (First) (Middle)

14 EINSTEIN STREET

(Street)

NESS ZIONA 7403618

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share	7,672	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	06/01/2019	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	66,489	$2.69	D
Option (right to buy)	(1)	11/17/2032	Ordinary Shares, par value NIS 0.40 per share	3,382	$5.34	D

Explanation of Responses:

1. The option vests ratably on an annual basis for 4 consecutive years beginning on November 17, 2023.

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Shachar Shlosberger, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)